Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience

키워드

참고문헌 (70)

1. Gregoire V, "Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up", Ann Oncol, 21(Suppl 5), pp.v184~v186 (2010)
2. Sturgis EM., "Second primary malignancies in the head and neck cancer patient", Ann Otol Rhinol Laryngol, 104(12), pp.946~954 (1995)
3. Roman BR., "AHNS Series-Do you know your guidelines? : guideline recommended follow-up and surveillance of head and neck cancer survivors", Head Neck, 38(2), pp.168~174 (2016)
4. Digonnet A., "Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma", Eur Arch Otorhinolaryngol, 270(7), pp.1981~1989 (2013)
5. Hermans R., "Laryngeal or hypopharyngeal squamous cell carcinoma : can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone?", Radiology, 214(3), pp.683~687 (2000)
6. Patel SN., "Salvage surgery for locally recurrent oropharyngeal cancer", Head Neck, 38(Suppl 1), pp.E658~E664 (2016)
7. Janot F., "Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma", J Clin Oncol, 26(34), pp.5518~5523 (2008)
8. Kramer NM., "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies", Head Neck, 27(5), pp.406~414 (2005)
9. Duprez F., "High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer : disease control, survival and toxicity", Radiother Oncol, 111(3), pp.388~392 (2014)
10. Kakria A., "Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients : a single institutional study", Asia Pac J Clin Oncol, 11(2), pp.129~134 (2015)
11. De Visscher AV., "Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity : does it make sense?", Arch Otolaryngol Head Neck Surg, 120(9), pp.934~939 (1994)
12. Ritoe SC., "Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality : results of a Markov model analysis", Cancer, 109(2), pp.239~247 (2007)
13. Lester SE, "‘When will I see you again?’ : using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients", Clin Otolaryngol, 34(6), pp.546~551 (2009)
14. Schwartz DL., "Postradiotherapy surveillance practice for head and neck squamous cell carcinoma : too much for too little?", Head Neck, 25(12), pp.990~999 (2003)
15. Boysen M., "The value of follow-up in patients treated for squamous cell carcinoma of the head and neck", Eur J Cancer, 28(2-3), pp.426~430 (1992)
16. Francis DO., "Impact of surveillance on survival after laryngeal cancer in the medicare population", Laryngoscope, 119(12), pp.2337~2344 (2009)
17. Flynn CJ., "The value of periodic follow-up in the detection of recurrences after radical treatment in locally advanced head and neck cancer", Clin Oncol (R Coll Radiol), 22(10), pp.868~873 (2010)
18. Agrawal A., "Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance", Laryngoscope, 119(11), pp.2135~2140 (2009)
19. Cooney TR., "Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?", Arch Otolaryngol Head Neck Surg, 125(4), pp.379~382 (1999)
20. Hsu YB., "Role of chest computed tomography in head and neck cancer", Arch Otolaryngol Head Neck Surg, 134(10), pp.1050~1054 (2008)
21. Wang SJ, "Surveillance radiologic imaging after treatment of oropharyngeal cancer : a review", World J Surg Oncol, 13, pp.94~ (2015)
22. Kao J., "The diagnostic and prognostic utility of positron emission tomography", computed tomography-based follow-up after radiotherapy for head and neck cancer, 2009, pp.115(19), 4586~4594
23. Manikantan K., "Current concepts of surveillance and its significance in head and neck cancer", Ann R Coll Surg Engl, 93(8), pp.576~582 (2011)
24. Krabbe CA., "18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma : a prospective study", J Nucl Med, 50(12), pp.1940~1947 (2009)
25. Ho AS., "Impact of positron emission tomography", computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence, 2013, pp.119(7), 1349~1356
26. Dunsky KA., "PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient", Laryngoscope, 123(9), pp.2161~2164 (2013)
27. Lee DH., "Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma", Otolaryngol Head Neck Surg, 149(4), pp.579~586 (2013)
28. Jegu J., "Trends over three de cades of the risk of second primary cancer among patients with head and neck cancer", Oral Oncol Jan, 49(1), pp.9~14 (2013)
29. Schwartz LH., "Synchronous and metachronous head and neck carcinomas", Cancer Oct, 74(7), pp.1933~1938 (1994)
30. Do KA., "Second primary tumors in patients with upper aerodigestive tract cancers : joint effects of smoking and alcohol(United States)", Cancer Causes Control, 14(2), pp.131~138 (2003)
31. Trosman SJ., "Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy", JAMA Otolaryngol Head Neck Surg, 141(5), pp.457~462 (2015)
32. Kwon M., "Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival", Oncologist, 20(5), pp.546~553 (2015)
33. Jain KS., "Synchronous cancers in patients with head and neck cancer : risks in the era of human papillomavirus-associated oropharyngeal cancer", Cancer, 119(10), pp.1832~1837 (2013)
34. Gleich LL., "Recurrent advanced(T3 or T4)head and neck squamous cell carcinoma : is salvage possible?", Arch Otolaryngol Head Neck Surg, 130(1), pp.35~38 (2004)
35. Wong LY., "Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery", Head Neck, 25(11), pp.953~959 (2003)
36. Paniello RC., "Practice patterns and clinical guidelines for posttreatment follow-up of head and neck cancers : a comparison of 2 professional societies", Arch Otolaryngol Head Neck Surg, 125(3), pp.309~313 (1999)
37. "NCCN guidelines: NCCN guidelines for treatment of cancer by site" (2015)[URL]
38. Hwang HS., "Comparison of positron emission tomography", computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer, 2009, pp.119(10), 1958~1965
39. Wierzbicka M., "Comparison of positron emission tomography", computed tomography imaging and ultrasound in surveillance of head and neck cancer : the 3-year experience of the ENT Department in Poznan, 2011, pp.16(5), 184~188
40. Kangelaris GT., "Limited utility of routine surveillance MRI following chemoradiation for advanced-stage oropharynx carcinoma", Int J Otolaryngol, 2010, pp.904297~ (2010)
41. Vandecaveye V., "Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after(chemo)radiotherapy : correlation between radiologic and histopathologic findings", Int J Radiat Oncol Biol Phys, 67(4), pp.960~971 (2007)
42. "Education" (2016)[URL]
43. "Head and neck cancer: multidisciplinary management guidelines" (2011)[URL]
44. "Recommandations SFORL"[URL]
45. "Medisch Maatschappelijk Werk"[URL]
46. "Linee guida AIRO"[URL]
47. "Linee guida AIOM"[URL]
48. Kissun D., "Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic", Br J Oral Maxillofac Surg, 44(5), pp.371~376 (2006)
49. Ritoe SC., "Cancer recurrence after total laryngectomy: treatment options, survival, and complications", Head Neck, 28(5), pp.383~388 (2006)
50. Spector JG., "Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx", Laryngoscope, 111(6), pp.1079~1087 (2001)
51. O’Meara WP., "Follow-up of head and neck cancer patients post-radiotherapy", Radiother Oncol, 66(3), pp.323~326 (2003)
52. Zatterstrom U., "Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma", Anticancer Res, 34(11), pp.6593~6599 (2014)
53. Rennemo E., "Impact of second primary tumors on survival in head and neck cancer : an analysis of 2, 063 cases", Laryngoscope, 118(8), pp.1350~1356 (2008)
54. Ferreira BC., "Assessment and topographic characterization of locoregional recurrences in head and neck tumours", Radiat Oncol, 10, pp.41~ (2015)
55. Shah K., "Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation", Oral Oncol, 51(5), pp.529~535 (2015)
56. Pagh A., "A longitudinal study of follow-up activities after curative treatment for head and neck cancer", Acta Oncol, 54(5), pp.813~819 (2015)
57. Joshi A., "Current trends in the follow-up of head and neck cancer patients in the UK", Clin Oncol (R Coll Radiol), 22(2), pp.114~118 (2010)
58. Merlano MC., "Impact of age on acute toxicity induced by bio-or chemo-radiotherapy in patients with head and neck cancer", Oral Oncol, 48(10), pp.1051~1057 (2012)
59. Ang KK., "Human papillomavirus and survival of patients with oropharyngeal cancer", N Engl J Med, 363(1), pp.24~35 (2010)
60. O’Sullivan B., "Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis", J Clin Oncol, 31(5), pp.543~550 (2013)
61. Bledsoe TJ., "Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy : patterns of failure and toxicity outcomes", Radiat Oncol, 8, pp.174~ (2013)
62. Subramaniam RM., "PET", CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer : evolving clinical imaging paradigm, 2014, pp.55(3), 431~438
63. Tiwana MS., "25 year survival outcomes for squamous cell carcinomas of the head and neck : population-based outcomes from a Canadian province", Oral Oncol, 50(7), pp.651~656 (2014)
64. Russi EG., "Swallowing dysfunction in head and neck cancer patients treated by radiotherapy : review and recommendations of the supportive task group of the Italian Association of Radiation Oncology", Cancer Treat Rev, 38(8), pp.1033~1049 (2012)
65. Bakhshandeh M., "Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy", Int J Radiat Oncol Biol Phys, 85(2), pp.514~521 (2013)
66. Forastiere AA., "Long-term results of RTOG 91-11 : a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer", J Clin Oncol, 31(7), pp.845~852 (2013)
67. Ryu CH., "Risk factors for non-cancer health events in patients with head and neck squamous cell carcinoma", Ann Oncol, 24(4), pp.1049~1054 (2013)
68. van Agthoven M., "The costs of head and neck oncology : primary tumours, recurrent tumours and long-term follow-up", Eur J Cancer, 37(17), pp.2204~2211 (2001)
69. Lang K., "Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck", Arch Otolaryngol Head Neck Surg, 135(6), pp.582~588 (2009)
70. Vogelius IR., "Risk factors for radiation-induced hypothyroidism : a literature-based meta-analysis", Cancer, 117(23), pp.5250~5260 (2011)

관련 논문AI추천